Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
The FDA-approved drug Alectinib compromises SARS-CoV-2 nu... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
The FDA-approved drug Alectinib compromises SARS-CoV-2 nucleocapsid phosphorylation and inhibits viral infection in vitro
0
Authors
Tomer Yaron
48 more
Tomer Yaron
•
Harel Weinstein
46 more
•
Nicholas Heaton
Published
December 16, 2020
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to review
Share your thoughts on this paper...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Biochemistry
Chemistry
Medicine
Immunology
Show all topics
DOI
10.1101/2020.08.14.251207
License
cc-no
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Biochemistry
Chemistry
Medicine
Immunology
Show all topics
DOI
10.1101/2020.08.14.251207
License
cc-no
